VasQ for Kidney Failure
Trial Summary
Do I need to stop my current medications for the VasQ trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What data supports the effectiveness of the treatment VasQ for kidney failure?
Research shows that the VasQ device, used in creating arteriovenous fistulas (AVFs) for hemodialysis, improves the success and function of these fistulas, which are crucial for patients with kidney failure. Studies indicate that VasQ helps stabilize blood flow and increase the maturation and usability of AVFs, suggesting it could be effective for kidney failure treatment.12345
What is the purpose of this trial?
VasQ is an external support implant for arteriovenous fistulas created for dialysis access.This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms:* Treatment arm: End to side fistula supported with VasQ* Control: Standard of care end to side fistula
Research Team
John F Lucas III, MD, FACS, FSVS
Principal Investigator
Greenwood Leflore Hospital
Eligibility Criteria
This trial is for adults aged 18-80 with chronic kidney failure who need a new arteriovenous fistula for dialysis. Candidates must be able to attend follow-up visits over 12 months and consent to participate. Pregnant women are excluded.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the VasQ supported fistula or standard of care fistula
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- VasQ
Find a Clinic Near You
Who Is Running the Clinical Trial?
Laminate Medical Technologies
Lead Sponsor